Approach to Secondary Hypertension



Approach to Secondary Hypertension


Robert D. Brook

John D. Bisognano



Approximately 90% to 95% of people with hypertension have primary (essential) hypertension (1). This elevation of blood pressure is multifactorial in origin and probably represents a complex interaction of multiple genetic traits with lifestyle factors such as weight, sodium intake and excretion, and stress (2). In contrast, patients with secondary hypertension have a specific identifiable cause of the blood pressure elevation and may benefit by correction of the underlying defect. This chapter describes the most common causes of secondary hypertension, with particular focus on issues relating to patient management. It is important to remember that many people have secondary hypertension in addition to primary hypertension and that addressing the secondary issues can lead to reduction, but not necessarily elimination, of a patient’s need for other blood pressure-reducing therapy.

The Seventh Report of the Joint National Commission on the Evaluation and Treatment of High Blood Pressure recommends considering secondary causes of hypertension if blood pressure cannot be controlled (less than 140/90 mm Hg) by a combination of three drugs (3). This three-drug guideline alone, although generally reasonable, is likely to yield a high proportion of negative workups for secondary hypertension and may well be a relic of previous days when triple-drug treatment of hypertension was fraught with side effects and was viewed as maximal medical treatment. It also does not acknowledge the additional difficulty in reaching lower target blood pressure levels for diabetic patients (130/80 mm Hg) and for patients with severe renal insufficiency (125/75 mm Hg), which almost always require numerous medications (4). In addition, evaluation for secondary hypertension may be appropriate, regardless of blood pressure level or intensity of treatment, in other clinical scenarios. These include



  • Young patients (e.g., patients younger than 30 to 35 years),


  • A paucity of risk factors for primary hypertension (e.g., no obesity or family history),


  • Specific symptoms/signs suggesting a secondary etiology (e.g., spells, hypokalemia),


  • A sudden alteration in blood pressure level or control,


  • A history of hypertensive emergencies or repeated severe urgencies,


  • Severe or progressing target-organ damage (e.g., worsening renal function), or


  • Refractory hypertension (while taking appropriate triple-drug therapy).


GENERAL CLINICAL APPROACH

A suggested overall approach to evaluating the patient with difficult-to-control hypertension and with a possible secondary etiology is given in Table 13.1.


Verify Accuracy of Measurements

Before instituting an extensive evaluation for secondary causes of hypertension, the clinician must be certain that the blood pressure readings obtained are indicative of
the patient’s “true” blood pressure during the majority of the day. It is of foremost importance first to establish that the blood pressure-measurement methods are valid and accurate per established guidelines (5). Lack of attention to proper measurement techniques, even by trained medical staff (6) and cardiologists alike (7), can lead to false diagnoses of resistant hypertension. Among many common errors, careful attention should be given to using an appropriate arm-cuff size (particularly in obese patients), keeping the upper arm at heart level (mid-sternal), and allowing for a full 5-minute resting in a seated position before obtaining duplicate or triplicate readings (5). Physicians must confirm nonemergency hypertension by corroborating readings on several occasions and should not be overly concerned by intermittent, isolated, or a few sporadic asymptomatic high values.








TABLE 13.1. Overall approach to secondary hypertension
































































































POSSIBLE CAUSE OF SECONDARY
HYPERTENSION


SCREENING DIAGNOSTIC APPROACH
*FOLLOW-UP DIAGNOSTIC MEASURES


FIRST: EVALUATE FOR COMMON REVERSIBLE ETIOLOGIES OF SEVERE HYPERTENSION


White-coat hypertension or resistance


Home blood pressure measurements



*24-hr ambulatory monitoring in some patients


Medical noncompliance


Focused history, including drug cost and side effects and patient’s knowledge of the drugs



*Possible admission to the hospital for observed medical therapy in rare cases


Pseudohypertension


Assure accuracy in blood pressure measurement



Assure use of appropriate medical regimen



*Wrist, finger, or intraarterial measurement



*History of paroxysmal hypertension syndrome



*Consider aortic blood pressure measurement in rare situations


AFTER ABOVE SITUATIONS ARE APPROPRIATELY ADDRESSED, THE NEXT STEP INCLUDES EVALUATIONS FOR TRUE SECONDARY ETIOLOGIES


Exogenous drug use


Focused history, including over-the-counter drugs



*Blood/urine drug-screening tests



*Hospital admission


Renal parenchymal disease


General blood chemistry, urinalysis, urine for microalbumin and protein



*More-detailed workup as required on follow-up


Renal artery stenosis


Noninvasive renal artery imaging, including MRA, CTA, duplex ultrasonography



*Angiography for confirmation and percutaneous treatment on a case-by-case basis


Primary aldosteronism


Screening test with serum potassium, ratio of serum aldosterone to plasma renin activity



*Confirmatory testing (saline suppression) and imaging (CT, MRI), as required on follow-up


Pheochromocytoma


Plasma free normetanephrines and metanephrines



Confirmatory testing (clonidine suppression) and imaging (CT, MRI) as required on follow-up


Cushing syndrome


24-hr urine for free cortisol



*Confirmatory testing and imaging as required on follow-up


Thyroid disease


TSH or free thyroxine


Parathyroid disease


Serum calcium



*Ionized calcium level, PTH as required


Obstructive sleep apnea


Sleep study



*CPAP trial


Aortic coarctation


CT, surface echocardiogram with appropriate window views, transesophageal echocardiogram


CPAP, continuous positive airway pressure; CT, computed tomography; CTA, computed tomography angiography; MRI, magnetic resonance angiography; PTH, serum parathyroid hormone; TSH, thyroid-stimulating hormone.




Rule Out White-Coat Resistance

Although office blood pressures are most commonly used, a sizable subset of patients have significant hypertension only in the physician’s office (“white-coat” hypertension). Recognizing the continued debate, white-coat hypertension (home daytime blood pressures less than 135/85 mm Hg) is generally considered a comparatively benign condition and does not usually require (more) treatment (8). Patients receiving multidrug treatment with elevated office readings, yet with controlled 24-hour ambulatory blood pressures, are at markedly lower cardiovascular risk than are those with sustained true hypertension out of the medical office setting (9). On the contrary, true labile, or “borderline” hypertension carries an increased risk of cardiovascular events (10) and generally warrants treatment. Home blood pressure readings or 24-hour ambulatory monitoring can be important in distinguishing a patient with true severe hypertension from one who simply has controlled hypertension that is significantly augmented in the physician’s office (i.e., “pseudoresistance”). A workup for secondary causes in a patient with near-normal home blood pressure readings is likely to be unrevealing, and the cost of home blood pressure monitoring is low in comparison with most secondary evaluations. Moreover, home blood pressure readings can prevent overtreatment in patients with labile blood pressure, decrease drug side effects, and increase the patient’s ability to adhere to prescribed medical regimens. Basing treatment decisions on home blood pressure values leads to adequate blood pressure control without compromising clinical outcomes (11). Therefore all patients with refractory office hypertension should have the diagnosis corroborated by ruling out “white-coat resistance” with either proper home blood pressure or 24-hour ambulatory monitoring or both.


Evaluate for Pseudohypertension

The confounding presence of pseudohypertension also is important to consider before undergoing a secondary hypertension evaluation (12). In elderly patients and those with renal insufficiency, conventional arm blood pressure measurement in a calcified and noncompressible brachial artery can lead to falsely elevated systolic cuff readings and to subsequent overtreatment. In these patients, alternative blood pressure-measuring devices such as wrist and finger monitors, or even arterial lines, can be useful to establish the “true” blood pressure. In addition, a number of patients with labile refractory hypertension actually have “paroxysmal hypertension syndrome.” During most times, blood pressure levels and variability are normal. However, frequent seemingly unprovoked paroxysms involve large blood pressure elevations, most often associated with somatic symptoms (e.g., headache, panic, skin flushing). In an attempt to find an organic cause of their problems, patients often blame the blood pressure increase as the cause of the symptoms. In actuality, the reverse relation is almost always the true one. This syndrome may also overlap with significant white-coat hypertension as well. This increasingly recognized phenomenon may be caused by underlying intermittent anxiety, stress, pain, or psychosocial problems such as
a previous traumatic life event (13). Most individuals will deny an obvious precipitant of the frequent, often very severe intermittent hypertensive episodes. This often leads to repeated negative evaluations for pheochromocytoma. Ambulatory blood pressure monitoring, calming nonjudgmental reassurance, focused testing to rule out worrisome diseases, and treatment of the underlying disorder (e.g., antidepressants, anxiolytics) can result in improved blood pressure control, less frequent paroxysms, and a reduction in the associated symptoms. Finally, a recently described phenomenon in young patients, termed pseudohypertension of the youth, should be considered in young patients who otherwise have no apparent cause for their hypertension (14). These individuals are typically tall, athletic young men between 15 and 30 years old with isolated systolic hypertension. Evaluation of central aortic blood pressures may demonstrate normal values despite an elevated brachial systolic pressure, possibly due to enhanced peripheral pressure amplification. However, the precise etiology, prevalence, and prognosis associated with this syndrome remains to be determined.


Assure Medical Adherence

In addition, the health care provider must assess a patient’s adherence to and persistence with prescribed treatment plans before embarking on an extensive workup for secondary causes of hypertension. This can often be a difficult task, and many clinicians overestimate the degree of adherence of their patients. In very rare circumstances, an admission to the hospital for observed therapy is even required. More commonly, a detailed history with a noncombative questioning style and an assessment of the patient’s knowledge of the medical regimen can reveal the level of adherence. Most patients do not consciously disregard medical advice. It is more common that incomplete adherence to the full drug regimen or misunderstandings or both are responsible for medical nonadherence (15). Moreover, medication side-effect profiles and ease of adherence should be assessed. Moderate to severe hypertension is often treated with multiple drugs that are expensive and have adverse side-effect profiles. Because of their power in reducing blood pressure, drugs such as clonidine, hydralazine, and minoxidil are often prescribed without regard for the patient’s ability to tolerate the combined side effects. In short, patients are often not eager to spend money each month to feel miserable, particularly when they generally seem well despite their elevated blood pressure. Assessing medical adherence to treatment of an asymptomatic disease such as hypertension is absolutely essential for successful treatment.

Finally, all of the numeric and physical data from a patient should be consistent before a secondary evaluation is considered. A patient with years of extremely elevated blood pressure but no evidence of any target-organ damage (microalbuminuria, left ventricular hypertrophy, retinal abnormalities) is unlikely to have sustained levels of blood pressure elevation out of the physician’s office and would be a poor candidate for a workup for secondary hypertension. Similarly, a patient with modestly elevated readings in the physician’s office but evidence of target-organ damage should be evaluated more aggressively. This may be a sign of “masked” hypertension (elevated ambulatory blood pressures significantly higher than office readings), which carries a poor prognosis (16).

Once the accuracy of the blood pressure measurements and pattern is confirmed and the patient’s history of medical compliance is reasonably documented, an evaluation for secondary causes of hypertension can proceed. A vast number of rare causes for secondary hypertension have now been identified. However, this chapter focuses on the evaluation and treatment of several of the more common secondary causes of hypertension that may be encountered in a general medical or cardiology outpatient practice (Table 13.1). Clinicians should be aware that the credentialed discipline of a Hypertension Specialist now exists and not delay in referring patients to such expert care as required.



EXOGENOUS DRUG USE

An appraisal for exogenous drug use is an important step in the evaluation of secondary (potentially reversible) causes of hypertension. Some of the more common drugs used by hypertensive patients include oral contraceptives and other estrogencontaining compounds, sympathomimetic drugs for weight loss and sinus congestion, stimulant drugs (e.g., amphetamines, cocaine), excessive alcohol, immunosuppressive drugs (e.g., cyclosporine), migraine medications (e.g., ergotamines and “triptans”), anabolic steroids, and nonsteroidal antiinflammatory drugs. Less commonly, some medications for depression (venlafexine, bupropion, monoamine oxidase inhibitors) have been associated with significant blood pressure elevations. It has also been recognized that the anti-vascular endothelial growth factor cancer drugs (e.g., bevacizumab) are capable of causing severe hypertension (17). Finally, herbal remedies may alter blood pressure. A full history of all nonpresciption drugs should be specifically addressed, as many patients fail to mention over-the-counter pills during routine histories.

A relatively large proportion of young women use oral contraceptive medications. Although these medications produce only small increases of blood pressure in most patients, a subset of patients experiences significant increases in systolic blood pressure, sometimes as great as 22 mm Hg. In one study, degree of hypertension was associated with increased age (older than 35 years), duration of antiovulatory therapy, and alcohol intake. The hypertensive effect of the medication reversed in 50% of the patients 3 to 6 months after discontinuation, leaving a residual elevation in blood pressure that was probably attributable to underlying primary hypertension. Estrogen replacement therapy does not appear to have a similar hypertensive effect (18). Indeed, large reductions in blood pressure, more than 20 mm Hg systolic, have been demonstrated among hypertensive young women after stopping oral contraceptives (19). Because the population of women who are at highest risk for renal artery fibromuscular dysplasia also includes a high relative percentage who use oral contraceptives, it may be worthwhile to consider a trial of discontinuation of oral contraceptives before embarking on an extensive evaluation (discussed later) for renal artery fibromuscular dysplasia.

Numerous sympathomimetic drugs can be purchased over the counter and at health food stores for the treatment of sinus congestion (pseudoephedrine) (20) or obesity (phenylpropanolamine and others) (21). The short-acting immediate-release formulations and higher doses of both drugs are associated with larger blood pressure increases (20,21). However, patients with controlled hypertension are not at greater risk for severe elevations in blood pressure. Cold remedies without these medications (e.g., Coricidin HBP) have been marketed. Nevertheless, the risks of short-term use of lower doses of longer-acting decongestant pills among patients with controlled hypertension are unknown. Physicians must weigh the risk-to-benefit ratio before recommending these drugs in patients with high blood pressure. Based on the recent reviews, it seems likely that these sympathomimetics will pose little absolute cardiovascular risk if used appropriately among patients with controlled hypertension. Over-the-counter and prescription drugs for weight loss (i.e., sibutramine) have also been associated with modest increases in blood pressure. These drugs can occasionally produce profound increases in blood pressure through peripheral vasoconstriction and tachycardia. Because many hypertensive patients are also overweight, it is useful to ask patients specifically whether they use over-the-counter weight-loss drugs during evaluation for secondary causes of hypertension. Inquiry should also be made about food supplements, because sympathomimetics may be included and because some products from overseas may not be labeled in English.

Recreational use of cocaine can cause transient severe spikes in blood pressure but results in no chronic elevation of blood pressure. The transient spikes can also lead to
significant myocardial ischemia and coronary spasm (22). Alcohol intake of more than 2 oz per day can be associated with severe hypertension resistant to medical therapy, and patients whose condition appears refractory to the effects of medical therapy should be questioned about alcohol intake. A reduction in alcohol intake, particularly among heavy drinkers, can result in substantial reductions in blood pressure. In such patients, the issue of compliance with the medical regimen should also be definitively evaluated before they embark on an extensive workup for other secondary causes of hypertension. Conversely, although short-term caffeine ingestion does increase blood pressure via vasoconstriction, little evidence indicates that long-term intake implies an increased risk for developing chronic hypertension (23).

More patients are receiving solid organ transplants each year, and a greater proportion of these patients are surviving longer. The immunosuppressive medications cyclosporine and tacrolimus produce nephrotoxicity and hypertension in the majority of patients. The virtually unavoidable side effects are necessary to permit adequate immunosuppression while minimizing use of steroid drugs (which can also cause hypertension through volume increase). The mechanism of the hypertension caused by cyclosporine and tacrolimus is unclear but may be related to activation of the sympathetic nervous system and to systemic/renal endothelial dysfunction (24). Because most patients’ survival depends on adequate dosing with these drugs, blood pressure must simply be treated (often to low target levels dictated by the underlying renal insufficiency) with the usual armamentarium of antihypertensive drugs. Isradipine is frequently the favored calcium channel blocker because of its lack of effect on cyclosporine metabolism.

Exogenous intake of anabolic steroid medications, primarily for bodybuilding, can lead to mild increases in blood pressure as a result of sodium retention. It may be important to counsel hypertensive patients who engage in bodybuilding to avoid exogenous steroid use and also to inform them that bodybuilding itself can exacerbate hypertension. Rarely, even physiologic topical testosterone therapy has been associated with significant hypertension, particularly among older individuals (25).

Finally, the increasing use of nonsteroidal antiinflammatory drugs can cause hypertension both acute and chronic, by causing an analgesic nephropathy. This class of drugs generally produces small, if any, elevation in blood pressure in most patients (26), but certain patients have a marked increase in blood pressure. It is important to consider nonsteroidal drugs as a cause of increased blood pressure, particularly in the elderly patients, who often use these drugs at high doses. Simply withholding these medications for a few weeks may result in normalization of blood pressure and eliminate the need to pursue a workup for other secondary causes of high blood pressure.


RENAL PARENCHYMAL DISEASE

Disease of the renal parenchyma can be responsible for acute and chronic hypertension. When a patient is first seen with a hypertensive crisis, it is mandatory to evaluate renal function through a general chemistry profile and a complete urinalysis. A large number of more detailed tests (e.g., serum protein electropheresis) may be appropriate, depending on the clinical scenario. Although abnormalities may be the result of the hypertension itself, evaluation for acute renal processes such as glomerulonephritis, renal artery embolism, worsening of ischemic nephropathy, microangiopathic disease, and bilateral ureteral obstruction should be considered (27). Other processes, such as vasculitis and high-dose nonsteroidal drug ingestion, also can lead to acute renal failure and hypertension, and prompt consultation with a nephrologist or, if indicated, a vascular surgeon or urologist should be made in these cases.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 18, 2016 | Posted by in CARDIOLOGY | Comments Off on Approach to Secondary Hypertension

Full access? Get Clinical Tree

Get Clinical Tree app for offline access